UNDERWRITING AGREEMENT between GLUCOSE HEALTH, INC., and EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERSUnderwriting Agreement • January 9th, 2023 • Glucose Health, Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledJanuary 9th, 2023 Company Industry JurisdictionThe undersigned, Glucose Health, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with EF Hutton, Division of Benchmark Investments, LLC, (hereinafter referred to as “you” (including its correlatives), or “EF Hutton” or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) for the purchase and sale of the Company’s common stock, par value $0.001 per share (the “Common Stock”) pursuant to the following terms:
Form of Lock-Up Agreement for Officers, Directors, and Holder(s) of more than 5% Common StockLock-Up Agreement • January 9th, 2023 • Glucose Health, Inc. • Medicinal chemicals & botanical products
Contract Type FiledJanuary 9th, 2023 Company Industry